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Glucans are polymers of D-glucose with differing linkages
in linear or branched sequences. They are constituents of
microbial and plant cell-walls and involved in important
bio-recognition processes, including immunomodulation,
anticancer activities, pathogen virulence, and plant cell-
wall biodegradation. Translational possibilities for these
activities in medicine and biotechnology are considerable.
High-throughput micro-methods are needed to screen
proteins for recognition of specific glucan sequences as a
lead to structure–function studies and their exploitation.
We describe construction of a “glucome” microarray, the
first sequence-defined glycome-scale microarray, using a
“designer” approach from targeted ligand-bearing glu-
cans in conjunction with a novel high-sensitivity mass
spectrometric sequencing method, as a screening tool to
assign glucan recognition motifs. The glucome microarray
comprises 153 oligosaccharide probes with high purity,
representing major sequences in glucans. Negative-ion
electrospray tandem mass spectrometry with collision-in-
duced dissociation was used for complete linkage analysis
of gluco-oligosaccharides in linear “homo” and “hetero”
and branched sequences. The system is validated using
antibodies and carbohydrate-binding modules known to
target - or -glucans in different biological contexts, ex-
tending knowledge on their specificities, and applied to
reveal new information on glucan recognition by two sig-
naling molecules of the immune system against pathogens:
Dectin-1 and DC-SIGN. The sequencing of the glucan oli-
gosaccharides by the MSmethod and their interrogation on
the microarrays provides detailed information on linkage,
sequence and chain length requirements of glucan-recog-
nizing proteins, and are a sensitive means of revealing un-
suspected sequences in the polysaccharides. Molecular
& Cellular Proteomics 14: 10.1074/mcp.M115.048272, 974–
988, 2015.
Glucan polysaccharides are polymers of D-glucose with
differing linkages in linear or branched sequences. They occur
as storage materials in animals, secreted virulence factors of
bacteria, and conserved structural components of cell walls
of yeasts, fungi, some bacteria, and plants. Polysaccharides
of this type are of considerable interest in biology, medicine,
and biotechnology and are acknowledged for their immuno-
stimulatory, anticancer, and health-promoting activities (1, 2);
for their elicitor activities in defense responses and signaling
in plants (3); and for acting as functional ingredients in human
nutrition (4). Unraveling recognition systems that mediate
these activities is highly desirable as a lead to effective trans-
lational applications.
Recognition systems involving glucan polysaccharides in-
clude those in mammals, such as recognition of fungal -glu-
cans by Dectin-1, the major receptor of the innate immune
system against fungal pathogens (5), and by natural or vac-
cine-induced protective antifungal antibodies (6, 7); also rec-
ognition of mycobacterial -glucan by the innate immune
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receptor DC-SIGN (dendritic cell-specific ICAM-3-grabbing
nonintegrin) (8); those in insects, such as the Drosophila
Gram-negative binding protein 3 (GNBP3) sensor protein,
which binds -glucans (9); and those in bacteria, such as
Brucella abortus, where cyclic -glucans can serve as viru-
lence factors (10).
Another important class of glucan-recognizing proteins com-
prises noncatalytic carbohydrate-binding modules (CBMs)1 of
bacterial glycoside hydrolases that mediate association with
substrate and increase catalytic activity, likely through a target-
ingmechanism or by driving enzyme specificity (11, 12). Notable
examples are CBMs of bacterial cellulolytic enzymes that pro-
mote enzymatic deconstruction of intact plant cell walls and that
are of industrial significance in the biofuel and bioprocessing
sectors (13, 14) and CBMs of rumen or commensal human
microbiota with roles in animal and human health (14, 15).
CBMs also have roles in other systems: for example, CBM-
containing enzymes as virulence factors of bacterial pathogens
(16) and CBM-containing human laforin that regulates glycogen
metabolism and for which mutations can lead to neurodegen-
erative disease (17). The number of putative glucan-binding
CBMs that have been identified and classified in the Carbohy-
drate-Active enZyme (CAZy) database (http://www.cazy.org) is
expanding, but relatively few have been experimentally investi-
gated for details of carbohydrate binding and fine specificity
(11).
Searching for and assigning the specificities of glucan-
recognizing proteins has thus become increasingly important.
It is desirable to have high-throughput and sensitive micro-
methods to screen for and characterize ligands for structure–
function studies toward effective exploitation in modern thera-
peutic, nutritional, agricultural, and biofuel-related technologies.
Carbohydrate microarrays have served to advance knowledge
on specificities of diverse carbohydrate-recognition systems
(18–22). Where the desired oligosaccharide probes are unavail-
able, microarrays need to be generated from ligand-bearing
glycomes (23). Using a prototype of such designer microarrays
of neoglycolipid (NGL)-probes (23) derived from oligosaccha-
ride fragments of glucans rich in 1,3- or 1,6-linked se-
quences, we showed that linear 1,3-linked glucose sequences
with degree of polymerization (DP) 10 or longer are bound by
Dectin-1 (24). Recognition of other types of glucan sequences
by Dectin-1 and the applicability of microarrays of diverse
gluco-oligosaccharide sequences to other glucan-recognizing
proteins required investigation. Cummings, Smith, and col-
leagues have developed the shotgun strategy (20) to create
glycome-scale “gangliome” and “human milk glycome” mi-
croarrays. In the shotgun microarrays, the printed probes may
not be sequence-defined before array construction and require
metadata-assisted glycan sequencing (MAGS), which com-
bines MS analysis (25), binding data with glycan-binding pro-
teins or antibodies, and exoglycosidase treatment after printing
(26, 27).
Mass spectrometry has become a primary technique in
carbohydrate structural analysis (28), and electrospray mass
spectrometry (ESI-MS) has been used to provide sequence
and partial linkage information on various types of oligosac-
charides (29–33). For neutral oligosaccharides, we have
found that tandem MS with collision-induced dissociation
(CID-MS/MS) in the negative-ion mode is particularly useful
and have successfully applied for oligosaccharide chain and
blood-group typing (34, 35) and for branching pattern analysis
(36).
This is because that some important linkages at certain
monosaccharide residues can be unambiguously determined
with high sensitivity without the need for derivatization and
anion complexation as previously recognized, e.g. in the area
of gluco-oligosaccharides, Cl-anion adduction has been
used to determine sequences of tetrasaccharides of dextran
(37).
Here, we describe a strategy using the designer approach
combined with negative-ion ESI-CID-MS/MS for constructing
a microarray of sequence-defined gluco-oligosaccharides
representing major sequences in glucans (glucome microar-
ray) as a tool for screening glucan-recognizing proteins and
assigning their recognition motifs (Fig. 1). We selected a com-
prehensive panel of glucan polysaccharides isolated from
plants, fungi, and bacteria with different sequences to repre-
sent the glucome. We used finely tuned chemical and enzy-
matic methods to partially depolymerize the polysaccharides
and prepare gluco-oligosaccharide fragments with different
chain lengths (up to DP-13 or DP-16). We developed a ESI-
CID-MS/MS method that enables linkage and sequence de-
termination of linear or branched gluco-oligosaccharides at
high-sensitivity and applied this to the sequencing of oligo-
saccharide fragments prepared. These sequence-defined
gluco-oligosaccharides were then converted into NGL probes
and used for construction of the microarray. The oligosaccha-
rides encompassed linear sequences with homo (single) link-
ages: 1,2-, 1,3-, 1,4- ,or 1,6- with  or  configurations; and
hetero (multiple) linkages: 1,3-, 1,4, or 1,6-; also branched
oligosaccharide sequences with 1,3 and 1,6-linkages.
To our knowledge, this is the first sequence-defined gly-
come-scale microarray constructed. We used 12 selected
proteins (antibodies and CBMs) known to target - or -glu-
cans to validate the approach. We then applied the microarray
analysis to Dectin-1 and DC-SIGN, which revealed new in-
sights into the specificities of these signaling molecules of the
innate immune system.
EXPERIMENTAL PROCEDURES
Materials—The proteins investigated and their reported oligosac-
charide recognition with references are given in supplemental Table
1 The abbreviations used are: CBM, carbohydrate-binding module;
NGL, neoglycolipid; DP, degree of polymerization; DC-SIGN, den-
dritic cell-specific ICAM-3-grabbing nonintegrin; CAZy, Carbohy-
drate-Active enzyme.
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S2. The details of proteins investigated and the polysaccharide and
oligosaccharide sources for preparation of glucan oligosaccharide
fractions, together with the other chemically synthesized and com-
mercially available gluco-oligosaccharides, are described in supple-
mental Methods.
Preparation of Oligosaccharide Fractions from Gluco-Fructosides
and Glucan Polysaccharides—Gluco-oligosaccharide mixtures with
differing chain lengths prepared by partial depolymerization of gluco-
oligosaccharide fructosides or polysaccharides using acid or enzyme
hydrolysis (as described below and summarized in supplemental
Table S1) were fractionated by gel filtration chromatography on a
Bio-Gel P4 or P6 column (1.6  90 cm) eluted with deionized water at
a flow rate of 15 ml/h. Alternatively, when the hydrolysates were in
limited amounts, a Superdex-Peptide FPLC column (Pharmacia Bio-
tech, Uppsala) was used for fractionation at a flow rate of 0.3 ml/min.
The eluates were monitored on-line by refractive index,and pooled
according to their glucose units, as determined by MALDI-MS. Quan-
titation of oligosaccharide fractions was by dot-orcinol assay (24)
FIG. 1. Neoglycolipid (NGL)-based designer glucome microarray with mass spectrometry as a tool to assign carbohydrate ligands
in glucan recognition. Ligand-bearing glucan polysaccharides, described in supplemental Fig. S1 and Table S1, were selected as sources of
gluco-oligosaccharides for construction of the microarray. A total of 121 gluco-oligosaccharide fractions were obtained with different DP after
partial depolymerization of polysaccharides and fractionation. ESI-CID-MS/MS method was developed using gluco-oligosaccharides with
known sequences and applied to determination of sequences of oligosaccharide fragments from polysaccharides. Gluco-oligosaccharides
were converted to NGL probes for microarray construction and interrogation with the glucan-recognizing proteins described in supplemental
Table S2.
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using glucose as standard. Unless otherwise specified, oligosaccha-
ride fractions that contained flanking shorter or longer components
additional to the major components were not resolved further. The
sizes and compositions of the oligosaccharide fractions are indicated
in supplemental Table S6A/B, which give the results of MALDI-MS
analyses of the NGL probes derived from each of the oligosaccharide
fractions.
Cyanobacterium gluco-oligosaccharide fructosides were subjected
to mild acid hydrolysis with 0.5 M TFA at 95 °C for 9 min to remove the
fructose as described (38). Partial depolymerization of the gluco-
oligosaccharides was then carried out with 0.5 M TFA at 95 °C for 140
min. TFA was removed by repeated coevaporation with MeOH; this
was followed by fractionation by FPLC to obtain 1,2-linked gluco-
oligosaccharides with Glc2 to Glc9 as major components (Cyano-2 to
Cyano-9, respectively).
Poria cocos glucan (Poria) was hydrolyzed with 10 mM TFA at
100 °C for 2 h. TFA was removed by repeated coevaporation with
MeOH, and oligosaccharides were fractionated by FPLC. The high
oligomers (DP-20) recovered from chromatography were retreated
with 10 mM TFA as above and rechromatographed, and the proce-
dures were repeated twice. The hydrolysates were then combined
and subjected to Bio-Gel P4 chromatography to obtain 12 1,3-linked
gluco-oligosaccharide fractions, Poria-2 to Poria-13. Contaminating
1,4-linked gluco-oligosaccharides (supplemental Results) were re-
moved by preparative high-performance (HP) TLC, having observed
that the 1,4-linked malto-oligosaccharides migrate slower than the
1,3-linked oligosaccharides (supplemental Fig. S6B), using alumi-
num-backed silica gel HPTLC plates (Merck) and a solvent system
n-propanol/H2O 7:3 (by volume). The plates were developed twice,
and the slower-migrating 1,4-linked contaminants were removed.
The purified oligosaccharides were analyzed by HPTLC and MALDI-
MS, and results with the Poria-7 fraction before and after HPTLC
purification are shown in supplemental Fig. S6B and 6C. A series of
1,3-linked oligosaccharide fractions 3 to 13, was thus obtained, with
Glc3 to Glc13 as major components (Poria-3 to Poria-13) (supplemen-
tal Results and Tables S7A).
A pool of malto-oligosaccharides obtained by acid hydrolysis of
maltodextrins was from V-LABS (Covington, LA) and used directly for
Bio-Gel P4 fractionation to obtain a series of 1,4-linked oligosac-
charide fractions 8 to 13, with Glc8 to Glc13 as the major components
(Malto-8 to Malto-13).
Dextran oligosaccharide mixture was obtained by treatment of the
polysaccharide (20 mg/ml) with 0.1 M HCl at 100 °C for 4 h. The
reaction was stopped by cooling to room temperature and neutral-
ization with equimolar NaOH solution. Desalting was performed by a
short mixed-bed cation (AG50  8) and anion (AG1  8) exchange
column. The desalted reaction mixture was subjected to Bio-Gel P4
fractionation to obtain 1,6-linked oligosaccharide fractions 2 to 13
with Glc2 to Glc13 as the major components (Dext-2 to Dext-13).
Linear 1,2 oligosaccharides derived from CG were obtained by
hydrolysis with 0.01 M HCl at 100 °C for 2 h after the removal of
succinyl side chains by treatment with 0.1 M NaOH (details will be
described by HZ and colleagues elsewhere). The reaction was
stopped by cooling to room temperature and neutralization with
equimolar aqueous NaOH solution. Desalting was performed by gel
filtration with a short (1.6  30 cm) Sephadex G10 column and the
oligosaccharides were fractionated by Bio-Gel P4 to obtain 1,2-
linked fractions 2 to 13 with Glc2 to Glc13 as the major components
(CG-2 to CG-13).
An acid hydrolysate of curdlan was obtained from Megazyme
(Wicklow, Ireland) to isolate the minor longer oligomers. The hydroly-
sate was enriched for DP-8 to DP-13 by ultrafiltration (molecular
weight cut-off 1000) before Bio-Gel P4 chromatography to obtain
1,3-linked fractions, 8 to 13, with Glc8 to Glc13 as the major com-
ponents (Curd-8 to Curd-13).
The acid hydrolysate of cellulose was prepared by controlled acid
hydrolysis of cellulose acetate and was provided by Megazyme. The
oligosaccharide mixture was fractionated by Bio-Gel P4 to obtain
1,4-linked fractions 2 to 13 with Glc2to Glc13 as the major compo-
nents (Cello-2 to Cello-13).
Pustulan (at 10 mg/ml) was treated with 0.2 M HCl at 100 °C for 8 h.
The reaction was stopped by cooling to room temperature and neu-
tralization with equimolar aqueous NaOH solution. Desalting was
performed by gel filtration with a short Sephadex G10 column, before
oligosaccharide fractionation by Bio-Gel P6 to obtain 1,6-linked
fractions. HPTLC analysis of the fractions showed that size hetero-
geneity was high and semipreparative HPTLC was used to enrich for
DP-2 to DP-8 (Pust-2 to Pust-8) (results not shown). Purification of
oligosaccharide fractions 9–13 proved not possible, and these were
used without further fractionation. There was evidence of -linked
mannose contaminant as detected by binding signals with ConA in
microarray analysis (supplemental Table S7B) of these fractions. The
mannose contaminant is considered minor (2% or less) as mannose
was not detected on the polysaccharide or on fraction 10 by NMR.
Therefore, fractions 9 to 13 are considered to contain Glc9 to Glc15 as
the major components (Pust-9 to Pust-15), as shown in supplemental
Table S6A.
Barley oligosaccharide mixture was obtained by hydrolysis of bar-
ley -glucan with a novel cellulase with high transglycosylation activ-
ity (Novozyme) at 37 °C for 30 min. The digest was fractionated by
Bio-Gel P4 to obtain oligosaccharide fractions 3 to 16 with Glc3 to
Glc16 as major components (Barley-3 to Barley-16) with mixed
1,3and 1,4-linkages.
Hydrolysis of grifolan and lentinan was carried out with 0.02 M TFA
at 100 °C for 12 h. After cooling to room temperature, the hydrolysate
mixture was centrifuged. The supernatant was coevaporated with
MeOH and fractionated by a short (1.6  36 cm) column of Bio-Gel
P6. The high (DP-20) and low ( DP-20) oligomer fractions, as
determined by MALDI-MS, were kept separately. The precipitate and
high oligomer fractions were combined and the TFA treatment pro-
cedure was repeated three times to increase the yield of low oligo-
mers. The low oligomer fractions were combined and subjected to a
final gel filtration to obtain, from grifolan, fractions 2 to 16 with Glc3 to
Glc16 as major components (Grifo-3 to Grifo-16) and from lentinan
fractions 2 to 13, with Glc2 to Glc13 as major components (Lenti-2 to
Lenti-13). Microarray binding data with the 1,4-glucose specific
TmCBM41 (Fig. 5B and supplemental Table S7B) indicated the pres-
ence of a minor 1,4-linked glucose contaminant in the lentinan
fractions, particularly those containing oligomers with DP-8 as ma-
jor components. This was corroborated by MS/MS (footnote in sup-
plemental Table S7A) and NMR (not shown).
Electrospray Mass Spectrometry—For glucose linkage and oligo-
saccharide sequence analyses, negative-ion ESI-MS and ESI-CID-
MS/MS were carried out on a Micromass Q-TOF mass spectrometer
(Manchester, UK). Nitrogen was used as desolvation and nebulizer
gas at a flow rate of 250 l/h and 150 l/h, respectively. Source tem-
perature was 80 °C, and the desolvation temperature 150 °C. A cone
voltage of 50 V was used for negative-ion detection and the capillary
voltage was maintained at 3 kV. MS/MS product-ion spectra were
obtained from CID using argon as the collision gas at a pressure of
0.17 MPa. The collision energy was adjusted between 17 and 28 V for
optimal fragmentation. For quasi-MS3 to obtain a further product-ion
spectrum from a selected fragment ion as the precursor, the cone
voltage was raised to 80 V to encourage the primary fragmentation. A
scan rate of 1.0 s/scan and data acquisition of 1 min were used for
both ES-MS and ES-CID-MS/MS experiments, and the acquired
spectra were summed for presentation. For analysis, oligosaccha-
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rides were dissolved in ACN/water (1:1, v/v), typically at a concentra-
tion of 15 pmol/l, of which 2 l was loop injected. Solvent (ACN/2
mM NH4HCO3, 1:1, v/v) was delivered by a Harvard syringe pump at
a flow rate of 10 l/min.
MALDI Mass Spectrometry—MALDI-MS was carried out for mo-
lecular mass determination of gluco-oligosaccharides and NGLs on a
Tof Spec-2E instrument (Waters, Manchester, UK). The oligosaccha-
rides were dissolved in H2O and NGLs in CHCl3/MeOH/H2O (25:25:8),
at a concentration of 10 pmol/l, and 0.5 l was deposited on the
sample target together with a matrix of 2,4,6,-trihydroxyaceto-
phenone for analysis. Laser energy was 100% (coarse) and 50%
(fine); resolution was at 1000.
NMR Analyses—For determination of sequence and anomeric con-
figuration by NMR, glucan polysaccharides and oligosaccharides in-
vestigated (500 g of each) were taken up in D2O 99.9% (Apollo
Scientific, Stockport, UK) exchanged by lyophilisation, then redis-
solved in 0.3 ml D2O and transferred to a 5 mm small-volume NMR
tube (Shigemi, Tokyo, Japan). NMR spectra were recorded at 600
MHz, 30 °C on either a Varian I nova or a Bruker Avance spectrom-
eter, or at 700 MHz using a Bruker Avance spectrometer equipped
with cryoprobe. 1D and 2D pulse sequences were supplied by the
equipment manufacturer. Chemical shifts are given relative to ace-
tone at 2.213 ppm (1H) and 33.0 ppm (13C).
Saturation Transfer Difference (STD) NMR—Oligosaccharide sam-
ples were prepared to a concentration of 1 mM in 10 mM phosphate
buffer, pH 7.2, and exchanged by lyophilisation before transfer to a 5
mm NMR tube. Protein was added to a concentration of 5 M,
yielding a protein/oligosaccharide ratio of about 1:100. Spectra were
recorded at 700 MHz using a Bruker Avance spectrometer equipped
with a cryoprobe, at a temperature of either 30 °C or 45 °C. Selective
saturation was achieved using a 50 ms adiabatic inversion pulse train
irradiating a 950 Hz (1.36 ppm) window at 50 ppm for off-resonance
irradiation and typically 7.5 ppm, and -0.3 ppm for protein irradiation.
32 transients of 16K complex points were collected for each irradia-
tion frequency. Processing and subtraction were performed in either
Bruker Topspin software or in MNova (Mestrelab Research, Santiago
di Compostela, Spain). STD enhancements were calculated as a
percentage of the unperturbed spectrum for each individual experi-
ment; where the results of more than one experiment were combined,
normalized values were used to improve precision.
Gluco-Oligosaccharide NGLs—Gluco-oligosaccharides were con-
verted to NGLs by oxime-ligation using the lipid reagent aminooxy-
functionalized 1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine
(AOPE) essentially as described (39). In brief, for gluco-oligosaccha-
rides ofDP-7 oligosaccharides (100 nmol) were dried and incubated
with AOPE (200 nmol) in a solvent (50 l) of CHCl3/MeOH/H2O
(10:10:1, by vol) at ambient temperature for 16 h before solvent
evaporation slowly (over the course of 1 h) at 60 °C; for the larger
oligosaccharides (DP- 7) of Malto-, Dext-, Curd-, and Cello- series,
and Pust-oligosaccharide DP-8, ten equivalents of AOPE were ap-
plied and incubation was prolonged to 24 h under acidic conditions
(CHCl3/MeOH/water/acetic acid, 25:25:8:1) at 60 °C. A modified pro-
cedure (details will be described by HZ and colleagues elsewhere)
was used for the large oligosaccharides that are particularly hard to
dissolve (Pust-series DP-8; Cyano-, Poria-, CG-, Barley-, Grifo-,
and Lenti-series DP-7 and the synthetic linear and branched gluco-
oligosaccharides). NGLs of 1,4-linked mannose and xylose oligo-
saccharides, used as controls, were from the Glycosciences library
of probes prepared by reductive amination with the amino lipid,
1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine (DHPE) (40).
Purification of the NGLs from reaction mixtures(40) was carried out
by semipreparative HPTLC for gluco-oligosaccharides in the range
of DP-2 to DP-6, and silica gel cartridge for DP-7. The purified
NGLs were analyzed by MALDI-MS (supplemental Table S6A-6C)
and HPTLC before quantitation by primulin staining on HPTLC
plates (40).
Carbohydrate Microarray Analyses—The information on the probe
ID, sequence and glucose-DP for the 158 NGLs included in the
microarrays is shown in supplemental Table S7A. The NGLs were
printed onto 16 pad nitrocellulose-coated glass slides using a non-
contact robotic arrayer in duplicate at two levels, 2 and 5 fmol/spot,
following established protocols (41). The binding signals elicited with
the proteins were related to dose of probe arrayed; the results at 5
fmol/spot are presented throughout. Microarrays of polysaccharides
were also constructed for analyses of the binding with the proteins
investigated (supplemental Fig. S1). The polysaccharides were taken
up in water, with the exception of curdlan polysaccharide that was
solubilized using mild alkaline solution (50 mM NaOH), and printed
onto 16 pad nitrocellulose-coated glass slides at a final concentration
of 0.1 and 0.5 mg/ml.
Microarray binding analyses were performed using AlexaFluor-
647-labeled Streptavidin for readout, essentially as described (41).
The His-tagged proteins were analyzed precomplexed with mouse
monoclonal anti-poly-histidine (Ab1) and biotinylated anti-mouse IgG
antibodies (Ab2), both from Sigma, at a ratio of 1:3:3 (by weight). The
protein–antibody complexes were prepared by preincubating Ab1
with Ab2 for 15 min at ambient temperature, followed by addition of
proteins and incubation for a further 15 min and diluted to the final
concentration of the proteins in the blocking solution made of 3%
(w/v) BSA from Sigma (A8577) in HBS (5 mM HEPES buffer pH7.4, 150
mM NaCl) with 5 mM CaCl2 (Blocker A). The final concentrations of the
proteins were: 15 g/ml for murine and human Dectin-1; 2 g/ml for
BhCBM-6 and TmCBM4–2; 1 g/ml for CmCBM6–2 and TmCBM41;
5 g/ml for CmCBM32–2 and CtCBM11.
The Fc-tagged murine Dectin-1 and DC-SIGN were analyzed
without precomplexing (at 20 and 2 g/ml, respectively) in the
blocking solution Casein (Pierce) diluted to 0.5% in HBS (Blocker B,
for Fc-Dectin-1) and in the blocking solution Casein diluted to
0.02% in HBS with addition of 1% BSA and 5 mM CaCl2 (Blocker C,
for Fc-DC-SIGN), followed by the biotinylated goat anti-human-IgG
(Vector) at 10 g/ml in the respective blocking solution for each
protein.
The antibodies were analyzed without precomplexing: 2G8-IgG
and 1H8-IgG at 0.1 g/ml and 1E12-IgM at 0.2 g/ml in Blocker C,
followed by the biotinylated anti-mouse-IgG or anti-mouse-IgM as
appropriate, both from Sigma at 10 g/ml in the same blocker; MOPC
104-E-IgM at 3 g/ml in Blocker A, followed by the biotinylated
anti-mouse-IgM (Sigma) at 10 g/ml in the same blocker. The biotin-
ylated proteins were analyzed using a single step overlay; these
included anti-dextran m3.41G6 and m16.4.12E at 1:500 in Blocker C;
and ConA at 2 g/ml in Blocker A.
Microarray data analysis was performed using a dedicated soft-
ware (42) developed by Mark Stoll of the Glycosciences Laboratory.
RESULTS
Development of Negative-Ion ESI-CID-MS/MS Method
for Linkage and Sequence Determination of
Gluco-Oligosaccharides
Diagnostic Fragmentation for Different Glycosidic Linkages—
For method development to determine at high-sensitivity (low
pmol) the linkages and sequences in gluco-oligosaccharides,
eight disaccharides were used that represent naturally occur-
ring glucose linkages, including 1,2-, 1,3-, 1,4-, and 1,6- with
both - and -configurations (Table IA).
The product-ion spectra of the four -anomeric disaccha-
rides with 1,2-, 1,3-, 1,4-, and 1,6-linkages are shown in Fig.
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2A-2D. Under the conditions selected each glucose linkage
isomer had a different fragmentation pattern. Glycosidic C-
type (43) cleavages resulting in fragment ions C1 at m/z 179,
arising from a neutral loss of 162 Da from the molecular ion at
m/z 341, were observed in the spectra of all disaccharides but
with different relative intensities. A-type fragmentation across
the saccharide ring gave particularly useful information on the
linkages: In the spectrum of the 1,2-linked kojibiose (Fig. 2A),
neutral losses of 18, 78 and 120 Da gave a distinctive set of
three ions at m/z 323, 263 and 221, as [M-H]-h, 0,4A2-h, and
0,2A2, respectively (-h denotes dehydration). For the 1,3-
linked nigerose, glycosidic cleavage C1 only was observed at
m/z 179, whereas A-type fragmentation was absent (Fig. 2B).
The 1,4- and 1,6-linked disaccharides each produced ex-
tensive A-type fragmentation in addition to the C1 ions: in the
spectrum of the 1,4-linked maltobiose (Fig. 2C) these were
the 0,2A2 (m/z 281),
0,2A2-h (m/z 263), and
2,4A2 (m/z 221)
arising from neutral losses of 60, 78 and 120 Da, respectively,
whereas in the spectrum of 1,6-linked isomaltobiose (Fig.
2D), these were the 0,2A2 (m/z 281),
0,3A2 (m/z 251), and
0,4A2
(m/z 221) arising from neutral losses of 60, 90, and 120 Da,
respectively. The -anomers of the 1,2-, 1,3-, 1,4-, and 1,6-
linked disaccharides (Table IA) gave product-ion spectra (not
shown) almost identical to those of their -anomers.
In sum, under the conditions established, each linkage pro-
duced a unique set of fragments that can be used for assign-
ment of the glucose linkages: A-type fragmentation with neu-
tral losses of 18/78/120 Da for 1,2-linkage, 60/78/120 Da for
1,4-linkage, and 60/90/120 Da for 1,6-linkage; the absence of
A-fragment is indicative of a 1,3-linkage (Table IB).
Linear Sequences with Homo-Linkages—We next investi-
gated if the distinctive fragmentation patterns derived from
disaccharides with single linkage can be extended to longer
chains. Each of the linear heptasaccharides with different
linkages that were used as representatives (supplemental Ta-
ble S3) were found to give uniquely different spectra, with a
fragmentation pattern similar to the corresponding disaccha-
ride (Fig. 2E-2H and supplemental Results). In the cases
where fragment ions were weak or absent in the lower mass
regions and insufficient to make unambiguous linkage assign-
ment, as for the 1,4-linked Malto-7 (Fig. 2G) and 1,6-linked
Dext-7 (Fig. 2H), further product-ion scanning using C-ions as
the precursors (quasi MS3) revealed the complete linkage
information: C4 ions (m/z 665) were fragmented (supplemental
Fig. S2), producing similar but stronger A-type fragment ions
in the lower mass region, indicating 1,4 and 1,6-linkages,
respectively.
Linear Sequences with Hetero-Linkages—The principles
established above were used to assess the utility of the
method for sequencing linear gluco-oligosaccharides con-
taining different linkage types. Pullu-4 has two1,4-linkages
and one 1,6-linkage (supplemental Table S3). The product-ion
spectrum (Fig. 3A) can be used to assign the three individual
linkages as well as their locations. The two A-ion sets derived
from losses of 60/78/120 recorded from the two consecutive
residues at the reducing side were identical to the fragmen-
tation pattern for the 4-linked Glc (Table IB), corresponding to
two 1,4-linkages. The ion set with -60/90/120 from C2 (m/z
341) (Table IB) can be used to assign the nonreducing termi-
nal 1,6-linkage. Other 1,4/1,6-linked gluco-oligosaccha-
rides Pullu-7 (supplemental Fig. S3) and the isomeric trisac-
charide pair Pano-3 and i-Pano-3 (supplemental Fig. S4) can
also be readily identified.
Barley oligosaccharides contain 1,3/1,4-linkages (sup-
plemental Table S3). The A-ion set -60/78/120 was similarly
used to assign the 4-linkage and the lone glycosidic C-ion
was used to identify the 3-linkage as shown in the spectrum
of Barley-4c (Fig. 3B) and -4b (Fig. 3C).
TABLE I
Fragmentations of gluco-disaccharides observed in negative-ion ESI-CID-MS/MS product-ion spectra to establish the features of fragmentation
of gluco-oligosaccharides
(A) Major fragment ions observed.
Disaccharides Sequence
Cross-ring cleavage Glycosidic cleavage
18 60 78 90 120 162
Kojibiose Glc1,2Glc MH	h – 0,4A2h –
0,2A2 C1
Sophorose Glc1,2Glc MH	h – 0,4A2h –
0,2A2 C1
Nigerose Glc1,3Glc – – – – – C1
Laminaribiose Glc1,3Glc – – – – – C1
Maltobiose Glc1,4Glc – 0,2A2
0,4A2h –
2,4A2 C1
Cellobiose Glc1,4Glc – 0,2A2
0,4A2h –
2,4A2 C1
Isomaltobiose Glc1,6Glc MH	h 0,2A2 –
0,3A2
2,4A2 C1
Gentiobiose Glc1,6Glc MH	h 0,2A2 –
0,3A2
2,4A2 C1
(B) Diagnostic neutral losses of A-type fragmentationgiving the dis-
tinctive fragment ion set for different linkages ofgluco-disaccharides,
also applicable to oligosaccharides.
A-type neutral losses* Linkage
18/78/120 -2Glc
– -3Glc
60/78/120 -4Glc
60/90/120 -6Glc
* The fragmentation ions are counted from the molecular ion
M-H	 and glycosidic C-ions; ’-’ indicates not detected.
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Branched Sequences—We further investigated the capac-
ity of our approach to branching pattern analysis. Four
branched oligosaccharides with a single or double Glc1,6-
branch on 1,3-nonasaccharide backbone (supplemental Ta-
ble S3) were also used to assess the approach. The product-ion
spectra (Fig. 3D-3F and supplemental Fig. S5) showed distinc-
tive fragmentation patterns: Only C-type cleavage occurred in-
dicating 3-linkage along the backbone and the gap of 324 Da,
equivalent to twoGlc units (162 2) within the full sets of C-ions
could be used for location of the branching point.
Collectively, the product-ion spectra of the oligosaccha-
rides analyzed demonstrated the utility of the negative-ion
ESI-CID-MS/MS method for sequence determination of single
or mixed linkages in linear and branched gluco-oligosaccha-
rides, as well as their locations within the oligosaccharide chain.
Application of ESI-CID-MS/MS to Sequence Determination
and Mixture Analysis
The method established was used for sequence determi-
nation of representative oligosaccharide preparations in each
linkage series (as indicated in supplemental Table S7A). Un-
suspected gluco-oligosaccharide sequences were also re-
vealed. Two examples are given below as representatives.
The pentasaccharide Barley-5a was isolated from barley
-glucan after digestion with a novel cellulase. The sequence
was predicted to be Glc1,3Glc1,4Glc1,4Glc1,4Glc. How-
ever, in addition to 1,4-linkage with ion set -60/78/120 and
nonreducing 1,3-linkage with absence of A-fragments, there
was an A-type ion set -60/90/120 in spectrum, identifying an
internal 1,6-linkage (Fig. 4A). The sequence could be as-
signed as Glc1,3Glc1,4Glc1,6Glc1,4Glc, which was
FIG. 2. Negative-ion ESI-CID-MS/MS product-ion spectra of gluco-disaccharides and linear gluco-heptasaccharides with homo-
linkages. (A) Kojibiose with an 1,2-linkage. (B) Nigerose with an 1,3-linkage. (C) Maltobiose (Malto-2) with an 1,4-linkage. (D) Isomaltobiose with
an 1,6-linkage. (E) Cyano-7 with 1,2-linkages. (F) Lam-7 with 1,3-linkages. (G) Malto-7 with 1,4-linkages. (H) Dext-7 with 1,6- linkages.
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corroborated by NMR (supplemental Results and supplemen-
tal Table S4).
The Poria cocos polysaccharide (44) was selected as a
source of 1,3-linear gluco-oligosaccharides. However, the
product-ion spectrum of the isolated Poria-7 fraction showed
not only C-ions consistent with 1,3-linkage but also weak
A-type ions at -60/78/120 typical of 1,4-linkage (Fig. 4B and
supplemental Results). These results, together with initial mi-
croarray binding data with the 1,4-glucose specific
TmCBM41 (supplemental Table S2), showing unpredicted
binding to Poria-oligosaccharide fractions analyzed as NGLs
(supplemental Fig. S6A), indicated the presence of a 1,4-
linked glucose contaminant. This was corroborated by NMR
(supplemental Table S5). After repurification, there were no
longer signals for 1,4-linked glucose in the spectrum, and
TmCBM41 binding signals were greatly reduced, indicating
that the contaminant was largely removed.
Construction and Validation of the Glucome Microarray
as a Tool for Analysis of Glucan-Recognition
Representative gluco-oligosaccharide fractions (e.g. the
heptasaccharide fractions) prepared in each series were se-
quenced by the ESI-CID-MS/MS and the results corroborated
by NMR (data not shown). The oligosaccharides were then
converted into NGL probes by oxime-ligation to an aminooxy-
functionalized-lipid. The oxime-linked NGLs have a significant
proportion of the lipid-linked monosaccharide cores in ring-
closed form as there is no reduction involved in the conjuga-
tion reaction (39). The conditions for preparation of the NGLs
from the large oligosaccharides (DP-7) were optimized in
order to overcome the well-known solubility problem, partic-
ularly with the long chain gluco-oligosaccharides. The NGLs
were analyzed by MALDI-MS (supplemental Tables 6A-6C).
The 153 gluco-oligosaccharide NGLs together with five xylo-
and manno-oligosaccharide NGLs as controls (supplemental
Table S7A) were printed on nitrocellulose-coated glass slides
at 2 and 5 fmol/spot.
For validation, the microarray was probed with 12 glucan-
recognizing proteins: six monoclonal antibodies (mAbs) and
six microbial CBMs for which the recognition features had
been described using different methods; these, together with
the respective references, are summarized in supplemental
Table S2. The reported features were used for validation.
Additional specificities were also revealed using the newly
constructed microarrays. Salient findings are described
below.
Narrow Binding Profiles of Anti--glucan Antibodies—Three
mAbs had highly restricted binding to linear -linked se-
FIG. 3. Negative-ion ESI-CID-MS/MS product-ion spectra of linear gluco-tetrasaccharides with mixed linkages and branched
gluco-decasaccharides. (A) Pullu-4 (1,6,1,4,1,4 linkages). (B) Barley-4c (1,4,1,3,1,4 linkages). (C) Barley-4-b (1,4, 1,4, 1,3 linkages). (D)
HE-10B2. (E) HE-10B3. (F) HE-10B5.
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quences (Fig. 5A and supplemental Tables S7A/B). MOPC
myeloma 104-E-IgM showed binding exclusively to linear
1,3-oligosaccharides, particularly strongly to DP-4 to DP-8.
The anti-1,6-dextran hybridoma antibodies, 16.412E-IgA
(cavity-type) and 3.4.1G6-IgG3 (groove-type), showed the
predicted binding to 1,6-dextran oligosaccharides, DP-3
and DP-5, respectively. The 16.4.12.E-IgA differed and
showed additional binding to Pullu-4 and -7 (probes 52 and 53,
supplemental Tables S7A/B), which have in common the tetra-
saccharide sequence Glc1,6Glc1,4Glc1,4Glc with 1,6-link-
age at their nonreducing termini. This indicates that the cavity-
type antibody 16.4.12.E-IgA recognizes the nonreducing
terminal capping 1,6-disaccharide motif and that the internal
1,4-linked trisaccharide can serve to present this motif without
interfering. However, the groove-type 3.4.1G6-IgG3 requires
1–6 linkage throughout the chains. The weak binding signals
observed with the probe derived from the 1,2-linked DP-11
with both antibodies are unexplained and require investigation.
Binding Profiles of Vaccine-Induced Anti--glucan Anti-
bodies—The murine hybridoma antibodies 2G8-IgG, 1H8-IgG
and 1E12-IgM, induced upon immunization with a Candida
albicans -glucan, bound exclusively to -linked sequences
(Fig. 5A). Antibodies 2G8-IgG and 1H8-IgG bound only to
1,3-gluco-oligosaccharides (DP-3 or DP-4) among the lin-
ear sequences, whereas the 1E12-IgM gave binding to all
-linked sequences as short as DP-2, weakest of all to 1,2-
linked. Both IgG antibodies also bound to the 1,3/1,6-
branched gluco-oligosaccharides derived by chemical syn-
thesis or isolated from branched polysaccharides. However,
the binding was relatively weak compared with linear se-
quences of the same chain length (see also supplemental Fig.
S9). The IgM antibody, unlike the IgG antibodies, gave robust
binding to the synthetic di-branched tetrasaccharide probe
157 (supplemental Tables S7A/B). The internal -linkage of
this probe is clearly not accommodated by the two IgG anti-
bodies, indicating their requirement for contiguous (DP-
3/-4) 1,3-linked sequences.
Footprints of Glucan Binding by Microbial CBMs—The six
glucan-binding CBMs analyzed belong to different CAZy fam-
ilies (supplemental Table S2 and references therein).
TmCBM41 showed the predicted binding to 1,4-gluco-
oligosaccharides (Fig. 5B). Strong binding was detected with
four pullulan-derived linear 1,4/1,6-linked oligosaccharides
(probes 50–53, supplemental Tables S7A/B). The binding sig-
nal intensities with i-Pano-3 (Glc1,4Glc1,6Glc) and Pullu-7
(Glc1,6Glc1,4Glc1,4Glc1,6Glc1,4Glc1,4Glc) were com-
parable to those of 1,4-linked gluco-oligosaccharides of the
same size. However, binding was not detected to isomeric
Pano-3 (Glc1,6Glc1,4Glc) or Pullu-4 (Glc1,6Glc1,
4Glc1,4Glc). This provides new evidence that internal 1,6-
linkage is better tolerated than that at the non-reducing end
by this CBM.
CtCBM11 showed binding exclusively to barley-derived ol-
igosaccharides (Fig. 5B), in agreement with the reported high
affinity to barley-derived tetrasaccharide Glc1,4Glc1,
4Glc1,3Glc with a reducing terminal 3-linkage. However, in
the microarray analysis only DP-7 (Glc1,4Glc1,4Glc1,
3Glc1,4Glc1,4Glc1,3Glc) and longer chain probes were
bound (probes 116–125, supplemental Tables S7A/B). The
reported weak affinity to linear 1,4-linked oligosaccharides
was not detected here, which may indicate that both the
sequence of 1,4-linkages adjacent to a 1,3-linked glucose
and chain length are important for recognition. This could also
explain the lack of binding to Glc1,4Glc1,4Glc1,3Glc
(probe 108) as mentioned above, as the conjugation of reduc-
ing end glucose of this tetrasaccharide to the lipid may have
hindered access of the protein to the binding epitope.
FIG. 4. Application of the negative-ion ESI-CID-MS/MS method
to sequence determination and in detection of unsuspected
gluco-oligosaccharide sequences. (A) MS/MS (upper panel) and
quasi-MS3 (lower panel) for sequencing a pentasaccharide Barley-5a
isolated from barley -glucan hydrolysate. (B) MS/MS of Bio-Gel P4
fraction of Poria cocos glucan oligosaccharide, Poria-7, before (upper
panel) and after (lower panel) removal of minor contaminant by semi-
preparative HPTLC.
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TmCBM4–2, as predicted, showed selective binding to
1,3-gluco-oligosaccharides among linear sequences, similar
to the binding by antibodies 2G8-IgG and 1H8-IgG, including
the relatively weak binding to 1,3/6-branched oligosaccha-
rides and the lack of binding to di-branched tetrasaccharide
probe 157 (Fig. 5B and supplemental Tables S7A/B). Under
FIG. 5. Validation of the glucome microarray with 12 glucan-recognizing proteins. (A) Murine monoclonal antibodies that recognize -
or -glucans: MOPC-104E-IgM, 16.4.12.E-IgA, 3.4.1G6-IgG3, 2G8-IgG, 1H8-IgG and 1E12-IgM. (B) CBMs of microbial glycoside hydrolases
of different CAZy families: TmCBM41, CtCBM11, TmCBM4–2, CmCBM32–2, BhCBM6 and CmCBM6–2. The microarrays included 153
gluco-oligosaccharide-NGLs for which the glucose linkages are indicated in the colored panels; these were linear sequences with homo
linkages: 1,2-, 1,3-, 1,4-, or 1,6-linked, with  or  configurations in the size range mostly of DP-2 to DP-13, some up to DP-16; linear with
hetero linkages: 1,4;1,6, ranging from DP-3 to DP-7 and 1,3;1,4 ranging from DP-3 to DP-16; branched with 1,3/1,6 linkages, DP-2 to
DP-13; and synthetic branched oligosaccharides with 1,3-linked linear DP-8 or DP-9 backbones, each with one or two 1,6-linked
mono-glucosyl branches and a DP-4 backbone with an internal 1,3 linkage and two 1,6-linked glucose branches. Two xylo- and three
manno-oligosaccharide NGLs were included as controls. Carbohydrate sequence information on these probes is in supplemental Table S7A.
The binding signals are depicted as means of fluorescence intensities of duplicate spots at 5 fmol of oligosaccharide probe arrayed (with error
bars) and are representative of at least two independent experiments; the numerical scores are given in supplemental Table S7B.
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the microarray analysis conditions, a minimum chain length of
DP-4 was required for binding.
For CmCBM32–2, oligosaccharide ligands have not been
described to our knowledge. In the microarray analyses,
CmCBM32–2 exhibited a similar binding profile to BhCBM6
(Fig. 5B), the latter, as predicted, showed binding to the linear
1,3-gluco-oligosaccharides. On-array inhibition data con-
firmed binding of CmCBM32–2 to short 1,3 oligosaccharides
(supplemental Fig. S8). The two CBMs also showed promi-
nent binding to linear 1,2-linked oligosaccharides and to
1,3/6-branched oligosaccharides. Binding could be de-
tected to oligosaccharides as short as DP-2 or DP-3. Of
note is the particularly strong binding of CmCBM32–2 to the
di-branched tetrasaccharide probe 157 compared with the
unbranched 1,3-gluco-tetrasaccharide probe 68 (supple-
mental Tables S7A/B and supplemental Fig. S9), suggesting
a possible involvement of the 1,6-branching in the
recognition.
CmCBM6–2 contains two binding clefts (A and B) that differ
in specificity (supplemental Table S2). Binding was ob-
served to linear 1,3- (attributable to cleft A), 1,4- (cleft A
and B) and mixed 1,3/1,4-linked oligosaccharides (cleft
B) (Fig. 5B) that collectively would account for the higher
binding intensities to a broader range of gluco-oligosaccha-
ride probes than the preceding three CBMs. A novel finding
was the robust binding to linear 1,2-gluco-oligosaccha-
rides, which has not been reported for CmCBM6–2. The
binding to all of the -linked gluco-oligosaccharides was
detected at DP-2 and longer.
In sum, these antibodies and CBMs showed robust binding
signals with differing binding patterns with respect to glucose
linkage, sequence, and oligosaccharide chain length, not only
agreeing with previous reports but also revealing novel
specificities.
Application of the Glucome Microarray in Delineating
Specificities of Two Signaling Molecules of the Immune
System
Strict Specificity of Dectin-1—An unusual chain length
requirement of Dectin-1 for binding to 1,3-linked linear
gluco-oligosaccharides of DP-10 or greater was demon-
strated in our earlier study in which only 1,3- and 1,6-
linked linear oligosaccharide probes had been prepared. An
important and frequently raised question remaining to be
addressed was whether Dectin-1 can mediate signaling
processes through interactions with other glucan se-
quences (45, 46). We now investigate here the range of
gluco-oligosaccharide sequences bound by Dectin-1 using
the glucome microarray.
Both the murine and human Dectin-1 behaved similarly (Fig.
6A and supplemental Fig. S7) and showed a highly restricted
binding profile to the higher oligomers DP-11 to DP-13 of the
linear 1,3-linked probes isolated from curdlan (probes 75–
77, supplemental Tables S7A/B). Binding was not detected to
any other type of sequence nor to the other 1,3-containing
oligosaccharides. Among the latter were chemically synthe-
sized 1,3-linked oligosaccharides, DP-8 and DP-9, with one
or two 1,6-linked mono-glucosyl branches (probes 152–156
and 158), or natural oligosaccharides isolated from branched
polysaccharides containing 1,3 and 1,6-linkages up to DP-
16, or those isolated from barley containing linear 1,3 and
1,4 linkages up to DP-16. The chain length requirement for
Dectin-1 binding was corroborated by an “on-array” inhibition
assay (supplemental Fig. S8).
Broad Binding Profile of DC-SIGN—The recognition of
fuco- and manno-oligosaccharides by DC-SIGN has been
thoroughly investigated. Information on the interactions of this
protein with gluco-oligosaccharides is limited to inhibition of
gp120 binding by gluco-disaccharides that are 1,4-, 1,4-,
and 1,3-linked (47) and binding of DC-SIGN expressing cells
to polyacrylamide neoglycoconjugates of gluco-disaccharide
and tetrasaccharide that are 1,4-linked (8).
Microarray analyses of DC-SIGN showed a broad binding
profile to gluco-oligosaccharides (Fig. 6B). There was strong
binding to 1,4-linked probes with DP-2 and DP-3. This is in
line with the reported interaction of DC-SIGN with Mycobac-
terium tuberculosis, through binding to its -glucan, a capsu-
lar polysaccharide consisting predominantly of 1,4-linked
glucose, which triggers the production of immunosuppressive
IL-10 by activated DCs (8). Similarly to the 1,4-linked, all
other gluco-oligosaccharide probes, DP-2 and DP-3 were
preferentially bound by DC-SIGN. A novel finding in the pres-
ent study is the prominent binding to 1,2-gluco-oligosaccha-
ride probes: The DP-5 and DP-6 were particularly strongly
bound, comparably to 1,4-linked glucose DP-2 and DP-3,
1,4-linked mannose DP-4 to DP-6 (Fig. 6B) and high-man-
nose N-glycans (not shown). There was also robust binding to
the synthetic 1,3-linked gluco-tetrasaccharide with two
1,6-linked glucose branches and an internal 1,3 linkage
(probe 157, supplemental Tables S7A/B).
These data highlight the contrasting behavior of these two
signaling receptors among the proteins investigated (Fig. 6B):
the long chain requirement and strict 1,3 specificity unique to
Dectin-1 and preference for short chains but a broad range of
glucose linkages/sequences for interaction with DC-SIGN.
DISCUSSION
Detailed assignments of binding specificities using intact glu-
can polysaccharides is hampered by the heterogeneous nature
of the polysaccharides and difficulties in their separation/purifi-
cation and unambiguous determination of glycan sequences
they contain. Partial depolymerization to prepare gluco-oligo-
saccharides has been a conventional method for detailed in-
vestigation of structure/activity of glucans. At the oligosaccha-
ride level, the difficulties in solubilizing the higher oligomers (e.g.
DP  7) is still a major problem to obtain sufficient amounts
oligosaccharides of high purity for bioactivity and structural
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studies. In the approach we describe here, we address this by
using a NGL-based microarray obtained from gluco-oligosac-
charides prepared by fine-tuned depolymerization and fraction-
ation/purification methods and the development of negative-ion
ESI-CID-MS/MS for complete linkage and sequence analysis.
Using multiple chromatographic means at microscale, we were
able to obtain gluco-oligosaccharides of relatively high purity as
demonstrated by validation with antibodies and other glucan-
recognizing proteins of known specificities. Both the microarray
and mass spectrometry are highly sensitive methods, and only
very small amounts of oligosaccharides are required, thus en-
abling detection and unambiguous assignment of specificity of
glucan recognition.
The partial fragmentation of the polysaccharides, the se-
quencing of the oligosaccharides by the negative-ion ESI-
CID-MS/MS method, and their interrogation on the micro-
arrays not only provide detailed information on linkage,
sequence, and chain length requirements of glucan-recogniz-
ing proteins but also, as described here, are a sensitive means
of revealing unsuspected sequences in the polysaccharides.
Glucan sequences recognized by the antibodies and CBMs
that we selected as reference proteins had been determined
FIG. 6. Application of the glucome-microarray to analyses of two signaling molecules of the immune system. (A) Murine Dectin-1 and (B)
human DC-SIGN analyzed as human Fc chimeras. (C) Comparison of the relative binding intensities of the three groups of proteins investigated:
(i) mammalian lectin receptors of the immune system; (ii) monoclonal antibodies; and (iii) microbial CBMs. The heat map representation highlights
the different glucan binding patterns revealed by the microarray analysis. The relative binding intensities were calculated as the percentage of the
fluorescence signal intensity at 5 fmol given by the probe most strongly bound by each protein (normalized as 100%).
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by independent methods such as inhibition of binding, ITC,
x-ray crystallography, or STD-NMR. The prior knowledge
served to validate the glucome microarray as a tool. At the
same time, the wide range of gluco-oligosaccharide se-
quences covered in the microarrays has broadened knowl-
edge on the specificities of BhCBM6 and CmCBM6–2, and
revealed the ligands for antibody 1H8 and CmCBM32–2 that
had not been investigated previously.
Unlike Dectin-1, other glucan-recognizing proteins investi-
gated, including CBMs with specificities for 1,3-linked glu-
cose, did not have requirements for long chains and gave bind-
ing signals with oligosaccharides as short as DP-2 or DP-3 (Fig.
6C). The chain length requirements observed in the microarray
analysis of these CBMs were correlated with the different
modes of 1,3-glucan interaction in solution using STD-NMR
(supplemental Fig. S10): CBMs that interact most strongly with
the nonreducing end bind to short DP-2 or DP-3 sequences in
the microarray, whereas those that interact with internal resi-
dues require longer chain lengths (supplemental Results).
Exquisite specificity of Dectin-1 for the linear 1,3-linkage is
apparent in this glucome microarray. Reports using synthetic
oligosaccharides as inhibitors (48, 49) of Dectin-1 binding are
in accord with the chain-length requirement of Dectin-1 for
linear 1,3-linked gluco-oligosaccharides. The 1,3/1,6-
branched oligosaccharides we examined were not bound by
Dectin-1. These included those from lentinan and grifolan
(analyzed up to DP-13 and DP-16, respectively) and the
chemically synthesized oligosaccharides with 1,3-linked
backbones of DP-8 and DP-9 with one or two 1,6-linked
mono-glucosyl branches. In contrast, these branched oligo-
saccharides were bound by mAbs and CBMs that do not have
such long-chain requirements (as depicted in supplemental
Fig. S9). A possible explanation for lack of binding of Dectin-1
to the branched probes is their lack of a linear 1,3-linked
backbone longer than DP-10, required by Dectin-1. We com-
ment further on reported Dectin-1 inhibitory activities of cer-
tain branched oligosaccharides in supplemental Discussion
and supplemental Table S8.
The glucome microarray has provided new insights into
glucan recognition by DC-SIGN. The finding that 1,2-linked
gluco-oligosaccharides are recognized by this signaling re-
ceptor is of potential functional significance, raising the pos-
sibility of interaction of DC-SIGN with B. abortus through
recognition of its cyclic 1,2-glucan. Although the probes in
the microarray were “linearized,” this observation maybe an
important clue to the involvement of DC-SIGN in the activa-
tion of dendritic cells by B. abortus cyclic 1,2-glucan (50).
This requires exploration in depth.
In conclusion, we demonstrate the effectiveness and versa-
tility of the glucome microarray for glucan recognition systems
that require access to short as well as long gluco-oligosaccha-
ride sequences with different linkages, sequences, and ano-
meric configurations. The microarray would be an effective tool
for probing diverse other glucan recognition systems in fields
including infection and immunity, also in functional analyses of
proteins encoded by plant cell wall polysaccharide-degrading
genes, while assisting the classification of newly identified
CBMs or CBMs assigned to known families in the CAZy data-
base. The present approach of designer microarrays coupled
with MS opens the way to applying these approaches to the
molecular dissection of immunostimulatory activities involving
Dectin-1 where the presence of linear 1,3-sequences is not
apparent (45, 46) and to assign carbohydrate recognition motifs
involved in medicinal polysaccharide-driven immunostimulatory
events (51).
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